Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

VIRTUAL REALITY TRAINING AFTER THORACIC SURGERY (VRTS)

7 luglio 2026 aggiornato da: Orcin Telli Atalay, Pamukkale University

Effects of Exercise Training With Virtual Reality After Thoracic Surgery

This study aims to investigate the effects of virtual reality-based exercise training after thoracic surgery. Participants undergoing lung resection surgery will be assigned to either a virtual reality exercise training group or a control group receiving standard care. Physical function, pulmonary function, exercise capacity, dyspnea, anxiety, depression, and quality of life will be evaluated before and after the intervention. The findings may help determine whether virtual reality-assisted exercise training improves postoperative recovery in patients undergoing thoracic surgery.

Panoramica dello studio

Stato

Completato

Condizioni

Intervento / Trattamento

Tipo di studio

Interventistico

Iscrizione (Effettivo)

30

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Luoghi di studio

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

  • Adulto
  • Adulto più anziano

Accetta volontari sani

No

Descrizione

Inclusion Criteria:

Age between 25 and 70 years Stable symptoms and no other disease affecting pulmonary function (e.g., scoliosis or ankylosing spondylitis) Good cooperation and ability to walk independently Patients who underwent thoracic surgery FEV1 > 2 L for pneumonectomy, > 1 L for lobectomy, and > 0.6 L for segmentectomy Maximum oxygen consumption (VO₂max) > 15-20 mL/kg/min Cycle ergometer performance > 83 W No severe visual impairment Approved for participation in exercise training by the operating physician Hodkinson Mental Test score > 6 Willingness to participate and provision of informed consent -

Exclusion Criteria:

Contraindications to pulmonary rehabilitation or physiotherapy, including unstable cardiovascular disease, severe pulmonary hypertension, severe uncorrectable hypoxemia, exercise-induced desaturation, rib fractures, subcutaneous emphysema, advanced osteoporosis, or thrombocytopenia Orthopedic or neurological disorders that may impair independent ambulation, exertional dyspnea, or exertional vertigo Requirement for repeat thoracic surgery due to previous thoracic surgical history Inability to establish verbal and/or auditory communication and cooperation Inability to cooperate due to psychological and/or perceptual impairments Withdrawal Criteria Development of unexpected chest pain during the study Occurrence of syncope or nausea during testing procedures Participants may withdraw from the study at any time without providing a reason Study Completion / Termination Criterion Achievement of the planned sample size

-

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Trattamento
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Nessuno (etichetta aperta)

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Comparatore attivo: Conventional Pulmonary Rehabilitation Group
Participants received conventional pulmonary rehabilitation and cycle ergometer training after thoracic surgery.
Altro: Conventional Pulmonary Rehabilitation and Cycle Ergometer Training
Participants received conventional pulmonary rehabilitation and cycle ergometer training after thoracic surgery.
Procedura: thoracic surgery
Participants underwent thoracic surgery (lobectomy, segmentectomy, pneumonectomy, or wedge resection) according to the clinical indication before receiving the assigned rehabilitation intervention.
Sperimentale: Virtual Reality Exercise Training Group
Participants received conventional pulmonary rehabilitation, cycle ergometer training, and virtual reality-based exercise training after thoracic surgery.
Altro: Conventional Pulmonary Rehabilitation and Cycle Ergometer Training
Participants received conventional pulmonary rehabilitation and cycle ergometer training after thoracic surgery.
Procedura: thoracic surgery
Participants underwent thoracic surgery (lobectomy, segmentectomy, pneumonectomy, or wedge resection) according to the clinical indication before receiving the assigned rehabilitation intervention.
Comportamentale: Virtual Reality Exercise Training
Participants received virtual reality-based exercise training in addition to conventional pulmonary rehabilitation and cycle ergometer training after thoracic surgery.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
FEV1
Lasso di tempo: From baseline to 2 weeks after hospital discharge
Forced expiratory volume in one second (FEV1) measured by spirometry.
From baseline to 2 weeks after hospital discharge
FVC
Lasso di tempo: From baseline to 2 weeks after hospital discharge.
Forced vital capacity (FVC) measured by spirometry.
From baseline to 2 weeks after hospital discharge.
FEF25-75
Lasso di tempo: From baseline to 2 weeks after hospital discharge.
Forced expiratory flow between 25% and 75% of forced vital capacity measured by spirometry.
From baseline to 2 weeks after hospital discharge.

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Pain Intensity
Lasso di tempo: Baseline, postoperative day 2, and hospital discharge (up to 7 days after surgery).
Pain intensity was assessed using the Visual Analog Scale (VAS).Pain intensity was assessed using the Visual Analog Scale (VAS), ranging from 0 to 10, where 0 indicates no pain and 10 indicates the worst imaginable pain. Higher scores indicate greater pain intensity.
Baseline, postoperative day 2, and hospital discharge (up to 7 days after surgery).
Exercise Capacity
Lasso di tempo: Baseline, postoperative day 2, and hospital discharge (up to 7 days after surgery)
Exercise capacity was assessed using the 1-minute sit-to-stand test.Exercise capacity was assessed using the 1-minute sit-to-stand test (1-min STS). The outcome was recorded as the number of completed sit-to-stand repetitions in one minute. Higher values indicate better exercise capacity.
Baseline, postoperative day 2, and hospital discharge (up to 7 days after surgery)
Anxiety and Depression
Lasso di tempo: Baseline, postoperative day 2, and hospital discharge (up to 7 days after surgery).
Anxiety and depression were assessed using the Hospital Anxiety and Depression. Anxiety was assessed using the Hospital Anxiety and Depression Scale - Anxiety subscale (HADS-A). Scores range from 0 to 21, with higher scores indicating greater anxiety symptoms. Depression was assessed using the Hospital Anxiety and Depression Scale - Depression subscale (HADS-D). Scores range from 0 to 21, with higher scores indicating greater depression symptoms.
Baseline, postoperative day 2, and hospital discharge (up to 7 days after surgery).
Dyspnea
Lasso di tempo: Baseline, postoperative day 2, and hospital discharge (up to 7 days after surgery)
Dyspnea was assessed using the Modified Borg Dyspnea Scale. Dyspnea was assessed using the Modified Borg Dyspnea Scale. Scores range from 0 to 10, where 0 indicates no dyspnea and 10 indicates maximal dyspnea. Higher scores indicate greater dyspnea severity.
Baseline, postoperative day 2, and hospital discharge (up to 7 days after surgery)
Oxygen Saturation
Lasso di tempo: Baseline, postoperative day 2, and hospital discharge (up to 7 days after surgery).
Peripheral oxygen saturation was measured before, immediately after, and 3 minutes after the 1-minute sit-to-stand test.Peripheral oxygen saturation (SpO₂) was measured using a pulse oximeter before, immediately after, and 3 minutes after the 1-minute sit-to-stand test. Oxygen saturation was recorded as a percentage (%), with higher values indicating better oxygenation.
Baseline, postoperative day 2, and hospital discharge (up to 7 days after surgery).
Length of Hospital Stay
Lasso di tempo: From the day of surgery until hospital discharge (typically within 7 days after surgery).
Length of hospital stay was recorded as the total number of days from surgery until hospital discharge. Shorter hospital stay indicates a better outcome.
From the day of surgery until hospital discharge (typically within 7 days after surgery).
Patient satisfaction
Lasso di tempo: Hospital discharge (up to 7 days after surgery)
Patient satisfaction was assessed using a short patient satisfaction questionnaire.Patient satisfaction was assessed using the Short Patient Satisfaction Questionnaire (SPSQ/HMKDF), which consists of 7 items rated on a 5-point Likert scale. Total scores range from 7 to 35, with higher scores indicating greater patient satisfaction.
Hospital discharge (up to 7 days after surgery)

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Sponsor

Pamukkale University

Investigatori

  • Investigatore principale: Orçin T ATALAY, PhD, Pamukkale University

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Effettivo)

24 ottobre 2024

Completamento primario (Effettivo)

27 febbraio 2026

Completamento dello studio (Effettivo)

27 febbraio 2026

Date di iscrizione allo studio

Primo inviato

26 giugno 2026

Primo inviato che soddisfa i criteri di controllo qualità

7 luglio 2026

Primo Inserito (Effettivo)

14 luglio 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

14 luglio 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

7 luglio 2026

Ultimo verificato

1 luglio 2026

Maggiori informazioni

Termini relativi a questo studio

Parole chiave

Termini MeSH pertinenti aggiuntivi

Altri numeri di identificazione dello studio

  • E-76351742-050.04-572695

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

NO

Descrizione del piano IPD

Individual participant data will not be shared because the study was conducted as part of an academic thesis project and the informed consent process did not include provisions for public sharing of de-identified participant-level data.

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Prove cliniche su Esercizio di formazione

Cerca prove simili

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

CROs by country

CROs in South Africa

Condizioni

Malattie rare

Interventi farmacologici

Supplementi dietetici

Sponsor / Collaboratori

Sedi

3
Sottoscrivi